M. Rapp - Concepedia

Concepedia

Author

M. Rapp

Also Known As

M J Rapp, M Rapp, M. J. Rapp, M. RAPP, M. Rapp, M. Rapp,, MICHAEL RAPP, Marie-Josée Rapp, Marie‐Josée Rapp, Rapp, M.

35

Publications

1.4K

Citations

14

H-Index

51

Concepts

All Affiliations

Inserm Centre Hospitalier Universitaire de Nantes Centre d'Investigation Clinique de Nantes

MR

About

M. Rapp is an author at Inserm specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	535
2	Health Sciences	3	3	393
3	Biochemistry	3	3	60
4	Engineering	1	1	27
5	Natural Sciences	1	1	19

M. Rapp

×

16

Publications

1.4K

Citations

14

H-Index

	Year	Citations
Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cells Sophie Derenne, Brett P. Monia, Nicholas M. Dean, Blood	2002	428
14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome. Hervé Avet‐Loiseau, Thierry Façon, Axelle Daviet, PubMed CytogeneticsMixed-phenotype Acute LeukemiaImmunologyPathologyTumor Biology	1999	197
CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma Nelly Robillard, Hervé Avet‐Loiseau, Richard Garand, Blood	2003	184
Metalloproteinases in Multiple Myeloma: Production of Matrix Metalloproteinase-9 (MMP-9), Activation of proMMP-2, and Induction of MMP-1 by Myeloma Cells Sophie Barillé‐Nion, Camélia Akhoundi, M. Collette, Blood	1997	182
High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Hervé Avet‐Loiseau, Jianyong Li, Thierry Façon, PubMed CytogeneticsImmunologyPathologyTumor BiologyHematological Malignancy	1998	181
An interleukin 1 receptor antagonist blocks the IL-1-induced IL-6 paracrine production through a prostaglandin E2-related mechanism in multiple myeloma. Régis Bataille, Patrice E. Poubelle, M. Rapp, PubMed Pge2 SynthesisImmune RegulationImmunologyCell DeathReceptor Antagonist	1995	35
Myeloma cells release soluble interleukin-6Ralpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage. Wilfrid Thabard, M Collette, Jean‐Luc Harousseau, PubMed Distinct MechanismsImmunologyPathologyImmunologic MechanismImmune System	1999	28
Disposition in rat of a new fluorinated, biocompatible, non-ionic telomeric carrier J. C. Maurizis, Muhlisun Azim, M. Rapp, Xenobiotica Plasma RadioactivityFaecal ExcretionEngineeringRadiopharmaceutical TherapyToxicology	1994	27
Metalloproteinases in Multiple Myeloma: Production of Matrix Metalloproteinase-9 (MMP-9), Activation of proMMP-2, and Induction of MMP-1 by Myeloma Cells Sophie Barillé‐Nion, Camélia Akhoundi, M. Collette, Blood	1997	21
DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells. D. Godenèche, M. Rapp, Alain R. Thierry, PubMed Dna DamageMolecular BiologyTumor BiologyToxicological MechanismMedicinal Chemistry	1990	19

Page 1